Biden campaign navigates COVID pause; Scientists begin to paint a picture of bird flu symptoms in humans; What could be the lasting impact of Trump’s ear wound?
Abbott’s sales increased 4% in Q2, slight revisions made to guidance
Merck asks DC federal court for IRA decision ‘as soon as practicable’; Roche finds success with new obesity drug candidate; Trump expresses doubt over vaccine efficacy to RFK Jr.
Johnson & Johnson boosts full-year outlook on strong Q2 sales numbers
J&J also lowered its full-year adjusted operational EPS guidance as a result of costs associated with recent strategic acquisitions that ‘more than offset the improvement.’
Five things for pharma marketers to know for Wednesday morning
Three takeaways from Hearst Magazines’ Mind Lab; UnitedHealth CEO explains Change Healthcare woes; WHO and UNICEF find plateau in childhood immunization rates.
Five things for pharma marketers to know for Tuesday morning